Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07790406

Surgical Outcome Of da Vinci Single-port Surgical System In Lung Cancer

Early-stage lung cancer represents a clinical challenge that, when diagnosed promptly, offers high chances of cure through lobectomy and lymphadenectomy. In addition to traditional surgery, robotic techniques have become established and have recently evolved further with the Single-Port system, which allows the procedure to be performed through a single subcostal incision rather than multiple openings between the ribs. This approach reduces invasiveness, postoperative pain, and recovery time, while maintaining the same oncological effectiveness and safety as standard techniques. This is a monocentric and non-profit collection of clinical data, both prospective and retrospective, from patients treated with this method, ensuring data privacy through coded information and compliance with current regulations; the study is independent and non-profit.

Recruiting

Interested in participating?

Request Info

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Istituto Europeo di Oncologia

Milan, Mi, 20141, Italy

Location status: Recruiting

Location contact

Monica Casiraghi, MD PhD

CONTACT

[email protected]

+390257489662

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • all patients with proven non-small cell lung cancer (NSCLC) clinical stage I (9th TNM edition), who have undergone or will undergo lobectomy plus radical lymph node dissection following the STS guide line

Exclusion criteria

  • no consent

Treatment and study plan

da Vinci Single Port

Procedure

U-RATS lobectomy

Primary outcomes

  1. Evaluation of experience

    Time frame: "From enrollment to the end of 5 year follow-up

    The objective of this study is to collect and describe IEO experiences in the use of the Da Vinci SP surgical system for anatomical lung resection.

Study contacts

Contact information is provided by the study sponsor or research team.

Monica Casiraghi, MD PhD

CONTACT

[email protected]

025748662

Sponsors and collaborators

Lead sponsor

European Institute of Oncology

Other

Registry information

Important dates

Study start
2026
Primary completion
2032
Study completion
2032
First posted
Aug 27, 2026
Registry last updated
Aug 27, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.